Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Asset Writedowns and Impairment (2020 - 2025)

Historic Asset Writedowns and Impairment for Sight Sciences (SGHT) over the last 6 years, with Q3 2025 value amounting to -$33000.0.

  • Sight Sciences' Asset Writedowns and Impairment rose 8421.05% to -$33000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $27000.0, marking a year-over-year increase of 12621.36%. This contributed to the annual value of -$106000.0 for FY2024, which is 12535.89% down from last year.
  • Sight Sciences' Asset Writedowns and Impairment amounted to -$33000.0 in Q3 2025, which was up 8421.05% from $26000.0 recorded in Q2 2025.
  • Over the past 5 years, Sight Sciences' Asset Writedowns and Impairment peaked at $458000.0 during Q2 2023, and registered a low of -$250000.0 during Q1 2023.
  • Over the past 5 years, Sight Sciences' median Asset Writedowns and Impairment value was $36000.0 (recorded in 2024), while the average stood at $73157.9.
  • Per our database at Business Quant, Sight Sciences' Asset Writedowns and Impairment soared by 121904.76% in 2022 and then tumbled by 31666.67% in 2023.
  • Quarter analysis of 5 years shows Sight Sciences' Asset Writedowns and Impairment stood at $139000.0 in 2021, then soared by 57.55% to $219000.0 in 2022, then plummeted by 99.09% to $2000.0 in 2023, then plummeted by 150.0% to -$1000.0 in 2024, then plummeted by 3200.0% to -$33000.0 in 2025.
  • Its Asset Writedowns and Impairment was -$33000.0 in Q3 2025, compared to $26000.0 in Q2 2025 and $35000.0 in Q1 2025.